Skip to main content
2025 DC/CSEM Professional Conference Main banner

Julie A. Lovshin, MD, PhD, FRCPC (she/her/hers)

Endocrinologist & Clinical Investigator
Sunnybrook Hospital, University of Toronto
University of Toronto
Toronto, Ontario, Canada

Dr. Julie Lovshin is a Clinician Investigator and Assistant Professor of Medicine in the Division of Endocrinology and Metabolism, in the Temetry Department of Medicine at the University of Toronto. Dr. Lovshin is a staff Endocrinologist at Sunnybrook Health Sciences Centre in Toronto, Ontario Canada, who specializes in diabetes clinical care.

Dr. Lovshin’s research training includes a PhD at the University of Toronto in the Institute of Medical Science, supervised by Dr. Daniel Drucker on incretin hormones, including GLP-1 and GLP-2. She completed her undergraduate Medical School training, Internal Medicine Residency and Post-Graduate Clinical Fellowship in Endocrinology and Metabolism at the University of Toronto. Dr. Lovshin then went on to pursue clinical research investigation as an Eliot Phillipson Scholar in the Temetry Department of Medicine at the University of Toronto in a Post-Doctoral Research Fellowship focused on investigating renal and hemodynamic functional pathways in Types 1 and 2 diabetes with Dr. David Cherney and Dr. Dan Drucker. During her fellowship, Dr. Lovshin also completed formal research methodology and epidemiology training at the Harvard School of Public Health, Boston, MA, USA.

Dr. Lovshin directs the Diabetes Complications Clinical Research Laboratory at Sunnybrook Health Sciences Research Centre, Toronto, Canada. Dr. Lovshin has authored more than 70 academic publications in the area of diabetes, and has served as invited speaker at numerous international conferences given her expertise in both the science of clinical use of GLP-1 receptor agonsits.

Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing); Canadian Cardiovascular Society: Speaker/Honoraria (Terminated, November 30, 2024); CPD Network Association: Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eli Lilly Canada: Speaker/Honoraria (Ongoing); Novo Nordisk Canada: Speaker/Honoraria (Ongoing); NovoNordisk: Speaker/Honoraria (Ongoing)

Presentation(s):